Who are Teal Health's decision-makers?
Teal Health's public leadership centers on Kara Egan, Avnesh Thakor, MD, PhD, Clinical provider team. Buying decisions vary by category but generally include executive, clinical, operations, product, compliance, security, and finance stakeholders.
- CEO
- Kara Egan
- CTO/key exec
- Avnesh Thakor, MD, PhD
- Founded
- 2020
- Employees
- 51-200 reported range
- HQ
- San Francisco, CA
- Notable
- Private; commercial launch
- Kara EganCo-founder & CEOSince 2020Leads commercialization of Teal's cervical-cancer screening platform.
- Avnesh Thakor, MD, PhDCo-founderFounderStanford professor and interventional radiologist behind the device concept.
- Clinical provider teamTelehealth and follow-up careCurrent care teamOwns eligibility, results review, and referral coordination.
Who leads Teal Health?
Kara Egan, Avnesh Thakor, MD, PhD, Clinical provider team are the key public leaders in this profile. Their backgrounds indicate where strategy, clinical credibility, operations, product, and commercialization decisions are likely anchored.
Who actually makes buying decisions at Teal Health?
For clinical, patient, or payer-facing software, buying decisions usually require executive sponsorship plus clinical, compliance, legal, security, finance, and product review. For GTM, workforce, or back-office tools, operations and finance may lead but compliance and security still gate deployment.
How is Teal Health organized as it scales?
Teal Health appears organized around product, clinical or healthcare operations, customer growth, compliance, data, and partnerships. Sellers should align outreach to the operational problem they solve instead of starting with only the CEO.
As of June 2026.Sources:Teal homepageTeal FDA approvalTeal $10M raise
Teal Health — frequently asked questions
